Teleflex Medical has received clearance from the FDA to
market the Hudson RCI Neb-U-Mask®, a respiratory device that allows for the
concurrent delivery of aerosolized medication and a high concentration of
medical gases to treat acute asthma exacerbations.
As a leading global supplier of disposable products for critical care and
surgical applications, Teleflex Medical is a leading global provider of medical
products and solutions.
The Neb-U-Mask addresses an unmet clinical need by allowing
the concurrent delivery of aerosolized medications and high concentrations of
oxygen or heliox. Its closed system design allows for delivery of high levels
of oxygen or heliox gas mixtures, particularly helpful for conditions such as
asthma.
Chronic disease
Asthma is a chronic inflammatory disease of the airways.
According to the National Asthma Education and Prevention Program, asthma
affects more than 22 million people in the US, and is one of the most chronic
childhood diseases.
It is estimated that asthma accounts for approximately 1 in
every 250 deaths worldwide.
During an acute asthma attack, a patient may be given oxygen
or heliox in combination with pharmacologic therapies. The challenge of this
treatment approach is the lack of a device that allows for the simultaneous
delivery of medical gases and aerosolized medication.
In a study published in the Annals of Emergency Medicine in
2002, low oxygen saturation has been correlated inversely with the rate of
hospitalization, which puts caregivers in a difficult situation when faced with
the choice of medication delivery over an interruption of high levels of oxygen
therapy.
The device from Teleflex Medical now caters for just this kind of challenge.
Whitney Reynolds, Director of Respiratory Care Marketing, reflects, “We are
pleased to add the Neb-U-Mask to our extensive line of asthma management
solutions.”
“At Teleflex Medical our ultimate goal is to provide
products and education programs to help patients with asthma live a normal,
healthy, and productive life. But knowing that acute asthma attacks are
prevalent, we must provide caregivers the tools they need to achieve positive
patient outcomes.”
